Demonstrações financeiras detalhadas de Karyopharm Therapeutics Inc. (KPTI): demonstração de resultados, balanço patrimonial e fluxo de caixa. Acompanhe a evolução de margens, dívida, liquidez e rentabilidade ano a ano com até 20 anos de histórico.
Resumo da Análise
Karyopharm Therapeutics Inc. registou receitas de $146.1M no último exercício, com um CAGR de 5 anos de 6.2%.
Margens dos últimos 12 meses: margem bruta 95.9%, margem operacional -56.2%, margem líquida -153.3%.
Ao preço atual de $1.70, KPTI apresenta lucros negativos (P/L não significativo) e um ROE de 77.63%. A capitalização de mercado é de $39M.
Demonstração de Resultados (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Receita | $154000 | $1.6M | $30.3M | $40.9M | $108.1M | $209.8M | $157.1M | $146.0M | $145.2M | $146.1M |
| Custo da Receita | $86.9M | $107.3M | $161.4M | $2.4M | $2.7M | $3.4M | $5.2M | $4.9M | $6.0M | $5.9M |
| Lucro Bruto | -$86.8M | -$105.7M | -$131.0M | $38.5M | $105.4M | $206.4M | $151.9M | $141.1M | $139.2M | $140.1M |
| P&D | $86.9M | $107.3M | $161.4M | $122.3M | $150.8M | $160.8M | $148.7M | $138.8M | $143.2M | $125.6M |
| Despesas Gerais e Administrativas | $23.9M | $24.9M | $48.8M | $105.4M | $126.4M | $143.8M | $145.4M | $131.9M | $115.4M | $105.2M |
| Despesas Operacionais | $110.9M | $132.1M | $210.2M | $227.8M | $277.2M | $304.7M | $294.1M | $270.6M | $258.7M | $230.8M |
| Lucro Operacional | -$110.7M | -$130.5M | -$179.9M | -$189.3M | -$171.8M | -$98.3M | -$142.2M | -$129.5M | -$119.4M | -$90.7M |
| EBITDA | -$108.7M | -$128.2M | -$175.2M | -$182.9M | -$167.9M | -$97.0M | -$139.3M | -$118.4M | -$38.6M | -$149.9M |
| Despesas com Juros | 0 | 0 | $2.5M | $15.6M | $27.1M | $26.0M | $25.0M | $23.8M | $37.4M | $45.8M |
| Lucro Antes de Impostos | -$109.4M | -$128.9M | -$178.4M | -$199.6M | -$196.0M | -$123.8M | -$164.9M | -$142.8M | -$76.4M | -$196.0M |
| Imposto | $139000 | $63000 | $26000 | $40000 | $309000 | $268000 | $369000 | $323000 | $57000 | $43000 |
| Lucro Líquido | -$109.6M | -$129.0M | -$178.4M | -$199.6M | -$196.3M | -$124.1M | -$165.3M | -$143.1M | -$76.4M | -$196.0M |
| LPA | $-43.80 | $-42.15 | $-47.11 | $-48.32 | $-40.87 | $-24.75 | $-30.28 | $-18.79 | $-9.41 | $-17.93 |
| LPA Diluído | $-43.80 | $-42.15 | $-47.11 | $-48.32 | $-40.87 | $-24.75 | $-30.28 | $-18.79 | $-9.41 | $-17.93 |
| Ações em Circulação (Diluídas) | $2.5M | $3.1M | $3.8M | $4.1M | $4.8M | $5.0M | $5.5M | $7.6M | $8.1M | $10.9M |
Demonstração de Resultados (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Receita | $44.0M | $34.1M | $35.1M | $33.4M |
| Lucro Bruto | $41.9M | $32.6M | $33.7M | $32.3M |
| Lucro Operacional | -$15.2M | -$17.8M | -$26.8M | -$22.5M |
| EBITDA | -$22.6M | -$89.6M | -$9.8M | -$53.9M |
| Lucro Líquido | -$33.1M | -$102.2M | -$22.4M | -$67.0M |
| LPA | $-3.82 | $-15.16 | $-1.02 | $-2.32 |
| LPA Diluído | $-3.82 | $-5.69 | $-1.24 | $-2.32 |
Balanço (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caixa e Equivalentes | $49.7M | $69.0M | $118.0M | $128.9M | $85.9M | $190.5M | $135.2M | $52.2M | $62.5M | $60.5M |
| Investimentos de Curto Prazo | $79.9M | $77.5M | $210.2M | $133.1M | $163.3M | $38.2M | $142.8M | $139.2M | $46.2M | $3.2M |
| Contas a Receber | 0 | 0 | 0 | $7.9M | $12.9M | $22.5M | $47.1M | $27.0M | $30.8M | $26.2M |
| Estoque | 0 | 0 | 0 | $346000 | $2.6M | $4.1M | $4.2M | $3.0M | $4.7M | $4.0M |
| Ativos Circulantes | $131.6M | $148.4M | $334.6M | $278.6M | $276.5M | $275.6M | $350.2M | $233.9M | $156.5M | $103.1M |
| Imobilizado | $2.8M | $2.2M | $3.9M | $13.7M | $11.6M | $9.6M | $7.4M | $4.9M | $6.3M | $4.7M |
| Ágio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ativos Intangíveis | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ativos Totais | $180.4M | $180.3M | $341.2M | $295.0M | $313.1M | $305.3M | $358.2M | $240.4M | $164.4M | $108.4M |
| Contas a Pagar | $4.8M | $5.7M | $4.3M | $985000 | $4.5M | $1.6M | $2.8M | $3.1M | $5.1M | $4.0M |
| Dívida de Curto Prazo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $24.4M | $21.0M |
| Passivos Circulantes | $16.5M | $49.5M | $46.9M | $46.4M | $60.2M | $73.7M | $65.9M | $69.5M | $92.3M | $92.1M |
| Dívida de Longo Prazo | 0 | 0 | $102.7M | $109.9M | $117.9M | $169.3M | $170.1M | $170.9M | $162.9M | $205.9M |
| Passivos Totais | $18.1M | $50.8M | $158.0M | $245.2M | $262.5M | $385.0M | $374.8M | $376.6M | $350.4M | $401.3M |
| Reservas | -$366.1M | -$495.3M | -$673.7M | -$873.3M | -$1.07B | -$1.18B | -$1.34B | -$1.49B | -$1.56B | -$1.76B |
| Patrimônio Líquido | $162.2M | $129.5M | $183.2M | $49.8M | $50.5M | -$79.7M | -$16.7M | -$136.2M | -$186.0M | -$292.9M |
| Dívida Total | 0 | 0 | $102.7M | $124.7M | $131.1M | $180.6M | $179.1M | $177.0M | $194.5M | $233.6M |
| Dívida Líquida | -$129.6M | -$146.5M | -$225.5M | -$137.3M | -$118.1M | -$48.0M | -$98.9M | -$14.4M | $85.8M | $169.9M |
| Capital de Giro | $115.2M | $99.0M | $287.7M | $232.2M | $216.3M | $201.9M | $284.3M | $164.4M | $64.2M | $11.1M |
Balanço (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caixa e Equivalentes | $37.7M | $60.5M | $90.8M | $55.0M |
| Ativos Totais | $96.2M | $108.4M | $131.4M | $111.3M |
| Passivos Totais | $365.5M | $401.3M | $397.1M | $441.5M |
| Patrimônio Líquido | -$269.3M | -$292.9M | -$265.6M | -$330.2M |
| Dívida Total | $196.4M | $233.6M | $230.9M | $215.9M |
Fluxo de Caixa (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Lucro Líquido | -$109.6M | -$129.0M | -$178.4M | -$199.6M | -$196.3M | -$124.1M | -$165.3M | -$143.1M | -$76.4M | -$196.0M |
| Depreciação e Amortização | $717000 | $713000 | $735000 | $974000 | $972000 | $789000 | $621000 | $530000 | $340000 | -$114000 |
| Compensação em Ações | $22.3M | $20.4M | $17.3M | $15.3M | $24.4M | $29.8M | $35.4M | $21.7M | $18.4M | $14.1M |
| Variação Capital de Giro | $987000 | $33.0M | -$169000 | -$13.3M | $1.4M | -$23.2M | -$20.0M | $31.4M | -$302000 | $28.3M |
| Fluxo de Caixa Operacional | -$84.4M | -$73.7M | -$159.1M | -$190.8M | -$160.2M | -$107.1M | -$149.6M | -$92.7M | -$127.5M | -$75.4M |
| CapEx | -$70000 | -$62000 | -$2.4M | -$206000 | -$145000 | -$5.7M | -$118000 | 0 | -$142000 | 0 |
| Aquisições | 0 | 0 | 0 | -$78.7M | $53.5M | $5.5M | $104.3M | 0 | 0 | 0 |
| Recompra de Ações | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fluxo de Caixa Livre | -$84.5M | -$73.8M | -$161.5M | -$191.0M | -$160.4M | -$112.8M | -$149.7M | -$92.7M | -$127.6M | -$75.4M |
Fluxo de Caixa (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Fluxo de Caixa Operacional | -$5.9M | -$11.8M | -$22.7M | -$24.9M |
| CapEx | 0 | 0 | 0 | 0 |
| Fluxo de Caixa Livre | -$5.9M | -$11.8M | -$22.7M | -$24.9M |
| Dividendos Pagos | 0 | 0 | 0 | 0 |
| Compensação em Ações | $2.8M | $3.9M | $3.0M | $1.9M |
Crescimento e Margens (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crescimento Receita (anual) | | +942.2% | +1790.1% | +34.8% | +164.3% | +94.1% | -25.1% | -7.0% | -0.5% | +0.6% |
| Crescimento Lucro Líquido (anual) | | -17.7% | -38.3% | -11.9% | +1.7% | +36.8% | -33.2% | +13.4% | +46.6% | -156.5% |
| Crescimento LPA (anual) | | +3.8% | -11.8% | -2.6% | +15.4% | +39.4% | -22.3% | +37.9% | +49.9% | -90.5% |
| Variação de Ações (anual) | | +22.3% | +23.7% | +9.1% | +16.3% | +4.4% | +8.8% | +39.5% | +6.7% | +34.6% |
| Crescimento FCF (anual) | | +12.6% | -118.9% | -18.3% | +16.0% | +29.6% | -32.7% | +38.0% | -37.6% | +40.9% |
| Margem Bruta | -56353.2% | -6583.7% | -431.9% | 94.1% | 97.5% | 98.4% | 96.7% | 96.6% | 95.9% | 95.9% |
| Margem Operacional | -71903.9% | -8133.2% | -593.0% | -462.9% | -159.0% | -46.8% | -90.5% | -88.7% | -82.2% | -62.1% |
| Margem EBITDA | -70598.1% | -7988.0% | -577.4% | -447.3% | -155.3% | -46.2% | -88.7% | -81.1% | -26.6% | -102.6% |
| Margem Líquida | -71153.9% | -8036.4% | -588.1% | -488.1% | -181.6% | -59.1% | -105.2% | -98.0% | -52.6% | -134.2% |
| Margem FCF | -54844.8% | -4596.8% | -532.3% | -467.1% | -148.4% | -53.8% | -95.3% | -63.5% | -87.9% | -51.6% |
| Taxa Efetiva de Imposto | -0.1% | -0.0% | -0.0% | -0.0% | -0.2% | -0.2% | -0.2% | -0.2% | -0.1% | -0.0% |
Dados por Ação (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Ação | $-33.76 | $-24.11 | $-42.64 | $-46.25 | $-33.39 | $-22.50 | $-27.42 | $-12.18 | $-15.71 | $-6.89 |
| Dividendo por Ação | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Ações em Circulação (Básicas) | $2.5M | $3.1M | $3.8M | $4.1M | $4.8M | $5.0M | $5.5M | $7.6M | $8.1M | $10.9M |
O que olhar em Biotech
A maioria das biotechs pequenas perde dinheiro. Analisar com P/E não faz sentido — olha caixa e pipeline.
- Cash Runway — Meses de caixa ao ritmo atual de gasto. <18 meses = risco de diluição urgente
- Cash burn anual — Ritmo a que queimam caixa operacional. Comparar com posição de caixa para projetar runway
- Dívida Total — Biotech sem receita + dívida = receita para falência
- I+D / Capitalização — Quanto investem em pipeline vs valor da empresa — indicador de intensidade de pesquisa
- Market cap / Caixa — Se cota perto do caixa, o mercado dá ~0 valor ao pipeline — oportunidade ou armadilha
Rentabilidade
| Retorno sobre patrimônio | 77.63% |
| Retorno sobre capital investido | 376.87% |
| Retorno sobre ativos | -201.89% |
| Margem bruta | 95.88% |
| Margem operacional | -56.17% |
| Margem líquida | -153.28% |
Saúde financeira
| Dívida / Patrimônio | -0.65 |
| Liquidez corrente | 0.79 |
Índices Chave (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/L | -3.22 | -3.41 | -2.98 | -5.94 | -5.67 | -3.89 | -1.68 | -0.69 | -1.08 | -0.41 |
| P/VP | 2.17 | 3.40 | 2.90 | 23.84 | 22.04 | -6.06 | -16.71 | -0.73 | -0.44 | -0.27 |
| P/V | 2287.93 | 274.25 | 17.53 | 29.01 | 10.30 | 2.30 | 1.77 | 0.68 | 0.57 | 0.55 |
| Margem Bruta | -56353.2% | -6583.7% | -431.9% | 94.1% | 97.5% | 98.4% | 96.7% | 96.6% | 95.9% | 95.9% |
| Margem Operacional | -71903.9% | -8133.2% | -593.0% | -462.9% | -159.0% | -46.8% | -90.5% | -88.7% | -82.2% | -62.1% |
| Margem Líquida | -71153.9% | -8036.4% | -588.1% | -488.1% | -181.6% | -59.1% | -105.2% | -98.0% | -52.6% | -134.2% |